查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1543948

全球介入性神經設備市場

Interventional Neurology Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球介入性神經設備市場將達49億美元

2023年全球介入神經設備市場估計為36億美元，預計2030年將達到49億美元，2023-2030年分析期間複合年成長率為4.6%。腦栓塞和動脈瘤彈簧圈栓塞裝置是本報告分析的細分市場之一，預計複合年成長率為 4.8%，到分析期結束時將達到 20 億美元。在分析期間，腦血管成形術和支架系統領域的複合年成長率預計為 3.1%。

美國市場預估價值9.743億美元，中國預期複合年成長率為4.3%

預計 2023 年美國介入性神經設備市場規模將達 9.743 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到7.736億美元，2023年至2030年複合年成長率為4.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.5% 和 3.7%。在歐洲，德國的複合年成長率預計為 3.8%。

全球介入神經科設備市場 - 主要趨勢和促進因素總結

什麼是介入神經設備？

介入性神經設備是用於微創治療中風、動脈瘤和動靜脈畸形 (AVM) 等神經血管疾病的專用醫療設備。這些設備包括導管、支架、栓塞彈簧圈和血栓移除系統，旨在引導大腦複雜而脆弱的脈管系統。介入性神經病學是現代醫學中至關重要的領域，因為它為患者提供了一種比傳統開放性手術侵入性更小的替代方案，從而縮短了康復時間，降低了併發症的風險，並改善了治療結果。隨著神經血管疾病的盛行率在全球範圍內持續上升，對先進介入神經設備的需求不斷增加，使其成為治療和管理這些危及生命的疾病的重要工具。

科技進步如何形塑介入神經設備市場？

技術進步正在顯著塑造介入神經設備市場，特別是透過影像處理、導管設計和材料科學方面的創新。高解析度 3D血管造影術和即時術中成像等診斷成像技術的進步透過提供腦血管系統的詳細可視化來提高神經血管手術的準確性和安全性。更靈活、可操縱的導管的開發提高了介入醫生在複雜動脈途徑中導航的能力，降低了血管損傷的風險並提高了手術成功率。材料科學的創新，包括使用生物相容性和滲透性材料，使支架和栓塞彈簧圈等設備更安全、更有效，從而更有效地治療複雜的神經血管疾病。這些技術趨勢正在推動介入性神經裝置在醫療保健環境中的採用，從而為神經血管疾病患者提供更有效、更侵入性的治療選擇。

為什麼醫療保健領域對介入神經科設備的需求不斷增加？

由於神經血管疾病的盛行率不斷增加、人口老化以及微創手術採用率的不斷提高，醫療保健領域對介入性神經設備的需求不斷增加。中風仍然是全球死亡和殘疾的主要原因，因此需要有效的治療方案，例如血栓切除裝置和栓塞彈簧圈。人口老化也增加了對介入神經設備的需求，因為老年人患動脈瘤和動靜脈畸形等需要先進介入治療的疾病的風險更高。患者和醫療保健提供者尋求開放性手術的替代方案，以實現更快的恢復時間、更短的住院時間和更低的併發症發生率。此外，介入神經科醫生的專業培訓和中風中心的擴張提高了醫療機構執行複雜神經血管手術的能力，並增加了這些設備的採用。隨著神經血管疾病負擔持續增加，介入神經器械的需求預計將增加。

推動介入性神經設備市場成長的因素有哪些？

介入性神經設備市場的成長受到多種因素的推動，包括技術進步、人口趨勢以及對微創治療的日益關注。主要促進因素之一是中風和動脈瘤等神經血管疾病的盛行率不斷上升，需要先進的介入設備進行有效治療。世界人口老化也是一個主要的成長要素，因為老年人更容易患上需要介入治療的神經血管疾病。對微創手術的日益偏好進一步推動了市場的發展。這是因為這些手術比傳統的開放性手術具有許多優點，包括更快的恢復和更低的併發症風險。影像處理、導管設計和材料方面的技術進步也透過提高介入神經手術的安全性、有效性和可及性來推動市場成長。此外，對醫療基礎設施的投資增加和專業卒中中心的擴張也為介入神經設備的採用創造了新的機會。隨著這些因素繼續影響醫療保健環境，對神經血管疾病的先進、有效和微創治療方案的需求預計將推動介入神經設備市場的持續成長。

調查企業範例（共43例）

  • Abbott Laboratories
  • ACANDIS GmbH
  • B. Braun Melsungen AG
  • Bayer AG
  • Biosensors International Group Ltd.
  • Boston Scientific Corporation
  • DePuy Synthes
  • evonos GmbH & Co. KG
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Surtex Instruments
  • Terumo Corporation
  • WL Gore & Associates, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP12822

Global Interventional Neurology Devices Market to Reach US$4.9 Billion by 2030

The global market for Interventional Neurology Devices estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Cerebral Embolization & Aneurysm Coiling Device, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Cerebral Angioplasty & Stenting Systems segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$974.3 Million While China is Forecast to Grow at 4.3% CAGR

The Interventional Neurology Devices market in the U.S. is estimated at US$974.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$773.6 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Interventional Neurology Devices Market - Key Trends & Drivers Summarized

What Are Interventional Neurology Devices and Why Are They Crucial in Treating Neurovascular Disorders?

Interventional neurology devices are specialized medical instruments used in the minimally invasive treatment of neurovascular disorders, such as strokes, aneurysms, and arteriovenous malformations (AVMs). These devices include catheters, stents, embolization coils, and clot retrieval systems, which are designed to navigate the intricate and delicate vasculature of the brain. Interventional neurology has become a crucial field in modern medicine, as it offers patients less invasive alternatives to traditional open surgeries, leading to faster recovery times, reduced risk of complications, and improved outcomes. As the prevalence of neurovascular disorders continues to rise globally, the demand for advanced interventional neurology devices is increasing, making them essential tools in the treatment and management of these life-threatening conditions.

How Are Technological Advancements Shaping the Interventional Neurology Devices Market?

Technological advancements are significantly shaping the interventional neurology devices market, particularly through innovations in imaging, catheter design, and materials science. Advances in imaging technologies, such as high-resolution 3D angiography and real-time intraoperative imaging, are enhancing the precision and safety of neurovascular procedures by providing detailed visualization of the brain’s vasculature. The development of more flexible and steerable catheters is improving the ability of interventionalists to navigate complex arterial pathways, reducing the risk of vessel injury and improving procedural success rates. Innovations in materials science, including the use of biocompatible and radiopaque materials, are enhancing the safety and efficacy of devices such as stents and embolization coils, making them more effective in treating complex neurovascular conditions. These technological trends are driving the adoption of interventional neurology devices across healthcare settings, as they enable more effective and less invasive treatment options for patients with neurovascular disorders.

Why Is There an Increasing Demand for Interventional Neurology Devices in Healthcare?

The demand for interventional neurology devices is increasing in healthcare due to the growing prevalence of neurovascular disorders, the aging population, and the rising adoption of minimally invasive procedures. Stroke remains a leading cause of death and disability worldwide, driving the need for effective treatment options such as thrombectomy devices and embolization coils. The aging population is also contributing to the demand for interventional neurology devices, as older adults are at higher risk for conditions such as aneurysms and AVMs that require advanced interventional treatment. The trend towards minimally invasive procedures is further fueling demand, as patients and healthcare providers seek alternatives to open surgeries that offer faster recovery times, reduced hospital stays, and lower complication rates. Additionally, the increasing availability of specialized training for interventional neurologists and the expansion of stroke centers are enhancing the adoption of these devices, as more healthcare facilities are equipped to perform complex neurovascular procedures. As the burden of neurovascular diseases continues to grow, the demand for interventional neurology devices is expected to increase.

What Factors Are Driving the Growth in the Interventional Neurology Devices Market?

The growth in the interventional neurology devices market is driven by several factors related to technological advancements, demographic trends, and the increasing focus on minimally invasive treatments. One of the primary drivers is the rising prevalence of neurovascular disorders, such as strokes and aneurysms, which require advanced interventional devices for effective treatment. The aging global population is also a significant growth factor, as older adults are more susceptible to neurovascular conditions that necessitate interventional care. The growing preference for minimally invasive procedures is further propelling the market, as these techniques offer numerous benefits over traditional open surgeries, including faster recovery and reduced risk of complications. Technological advancements in imaging, catheter design, and materials are also driving market growth by improving the safety, efficacy, and accessibility of interventional neurology procedures. Additionally, the increasing investment in healthcare infrastructure and the expansion of specialized stroke centers are creating new opportunities for the adoption of interventional neurology devices. As these factors continue to influence the healthcare landscape, the interventional neurology devices market is expected to experience sustained growth, driven by the need for advanced, effective, and minimally invasive treatment options for neurovascular disorders.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • ACANDIS GmbH
  • B. Braun Melsungen AG
  • Bayer AG
  • Biosensors International Group Ltd.
  • Boston Scientific Corporation
  • DePuy Synthes
  • evonos GmbH & Co. KG
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Surtex Instruments
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Interventional Neurology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Neurological Disorders Spurs Demand for Interventional Neurology Devices
    • Advancements in Imaging Technologies Propel Innovation in Neurovascular Interventions
    • Expansion of Minimally Invasive Surgical Techniques Drives Adoption of Neurology Devices
    • Shift Towards Catheter-Based Interventions Expands Market Opportunities
    • Role of Artificial Intelligence in Improving the Precision of Neurological Interventions
    • Increasing Use of Embolic Protection Devices Strengthens the Business Case for Adoption
    • Advancements in Thrombectomy Devices Propel Growth in Acute Stroke Management
    • Growing Importance of Early Diagnosis and Intervention in Neurovascular Conditions
    • Emerging Markets Present New Opportunities for Interventional Neurology Device Providers
    • Push for Cost-Effective Solutions in Stroke Treatment and Neurovascular Care
    • Role of Telemedicine and Remote Monitoring in Supporting Interventional Neurology
    • Increasing Focus on Patient-Centric Care and Customized Treatment Solutions
    • Growing Prevalence of Obesity Spurs Demand for Intragastric Balloons
    • Advancements in Minimally Invasive Weight Loss Solutions Propel Market Growth
    • Shift Towards Non-Surgical Bariatric Procedures Expands Market Opportunities
    • Rising Awareness of Obesity-Related Health Risks Drives Adoption of Intragastric Balloons
    • Increasing Focus on Lifestyle Modification and Weight Management Programs
    • Role of Multidisciplinary Approaches in Enhancing the Efficacy of Intragastric Balloons
    • Advancements in Balloon Design and Material Innovation Enhance Patient Safety and Comfort
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Interventional Neurology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cerebral Embolization & Aneurysm Coiling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Cerebral Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Neurothrombectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Support by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cerebral Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cerebral Artery Stenosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • JAPAN
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • CHINA
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • EUROPE
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • FRANCE
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • GERMANY
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030

IV. COMPETITION